Kenya Pushes Vaccine Independence as Experts Warn of Rising Child Deaths
By Peace Muthoka
Nairobi, February 11, 2026 – On Day Two of the KEMRI Annual Scientific and Health Research Conference (KASH), government leaders, scientists and international researchers gathered with a shared message: Kenya must fast-track vaccine manufacturing, tackle antimicrobial resistance and strengthen disease prevention systems to protect its children and secure its future.
Vision 2030 Delivery Secretariat Director General and Secretary to the Board Kenneth Mwige described health as the backbone of economic productivity and national stability.
“A healthy nation is a productive nation,” Mwige said, noting that counties receive about KSh 7 billion annually to run health services. He stressed that such investments must translate into better hospitals, stronger supply chains and modern standards of care.
He reminded participants that vaccines have saved more than 150 million lives globally in the last 50 years. Beyond preventing disease, he said, vaccines reduce child mortality, cut long-term healthcare costs and allow families to thrive.
For mothers like Achieng’ in Kisumu, who has lost two children to preventable infections, the conversation is deeply personal. “If there was a vaccine or better treatment, maybe my children would still be here,” she said quietly outside a county hospital last year. Her story mirrors thousands across the country, where preventable diseases continue to claim young lives.
Mwige said Africa must drastically reduce its dependence on imported vaccines. He cited the continental goal of achieving 60 percent vaccine manufacturing capacity by 2040. Kenya’s establishment of the Kenya BioVax Institute, he added, signals a bold step toward self-reliance.
“We cannot afford to wait for the next global crisis to expose our vulnerabilities,” he said.
However, vaccine production alone will not solve the crisis.
Experts at the conference raised alarm over the growing threat of antimicrobial resistance (AMR), warning that drug-resistant infections are increasingly contributing to preventable deaths, especially among children.
Dr. Ombeva Malande described vaccination as one of the most powerful tools in the fight against AMR. By preventing infections before they occur, vaccines reduce the need for antibiotics. That, in turn, slows the development of drug resistance.
“Every infection we prevent is an antibiotic course avoided,” Dr. Malande noted, emphasizing that overuse and misuse of antibiotics continue to drive resistance in communities.
The impact of antimicrobial resistance is already visible in pediatric wards across the country. Doctors report rising cases where common antibiotics fail to treat routine infections. For families, this often means longer hospital stays, higher medical bills and heartbreaking outcomes.
Adding a global research perspective, Professor Amy Pickering from the University of California, Berkeley, highlighted another silent driver of disease: environmental contamination.
Drawing from over 15 years of collaboration with KEMRI, she explained that unsafe water, poor sanitation and environmental pollution fuel the spread of enteric pathogens and antibiotic-resistant bacteria.
“When children are repeatedly exposed to unsafe water and contaminated environments, the health consequences can last a lifetime,” Prof. Pickering said.
She stressed that preventive strategies such as vaccination, improved water quality and better sanitation systems are not only cost-effective but essential. Protecting children from early-life exposure to harmful pathogens, she said, safeguards their growth, cognitive development and long-term wellbeing.
Throughout the discussions, one message stood out clearly: Kenya already has many solutions on paper. What the country needs now is swift and coordinated implementation.
Speakers called for stronger partnerships between academia, research institutions, industry and government. They urged leaders to move beyond policy formulation and focus on operationalizing existing scientific capacity.
The conference reaffirmed Kenya’s ambition to remain a regional and global leader in health research and innovation. As the country advances its Vision 2030 development agenda, experts agreed that integrating vaccine manufacturing, environmental health reform and antimicrobial resistance control will be central to strengthening national and continental health security.
For families across Kenya, these discussions are more than technical debates. They represent hope. Hope that the next generation will grow up healthier. Hope that no parent will have to bury a child because a vaccine was unavailable or an antibiotic failed.
As Kenya pushes forward with its vaccine independence agenda, the stakes are clear. Health security is no longer just a medical issue. It is an economic, social and moral imperative.
